Video
Dr. Stewart assesses novel renal cancer treatment
Author(s):
Video Player is loading.
In this video, Grant Stewart, MD, discusses future research based on the results from the study, “NAXIVA – a phase II neoadjuvant study of axitinib for reducing extent of venous tumor thrombus in clear cell renal cell cancer with venous invasion: translational results.” Stewart is a professor of surgical oncology and honorary consultant urological surgeon at the University of Cambridge, England, United Kingdom.
Related Videos
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Ekene Enemchukwu, MD, on guideline-associated trends in OAB therapy use
Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
Karyn S. Eilber, MD, on patient counseling for onabotA treatment for OAB
Optimizing onabotA for OAB: What are some common misconceptions?
Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
Perry Xu, MD, discusses PCNL’s role in the age of minimally invasive URS
Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen
Related Content
